- Plasmodium berghei
Taxobox
color = khaki
name = "Plasmodium berghei"
image_caption = Blood forms in red blood cells
image_width = 250px
regnum =Protista
phylum =Apicomplexa
classis =Aconoidasida
ordo =Haemosporida
familia =Plasmodiidae
genus = "Plasmodium "
species = "P. berghei"
binomial = "Plasmodium berghei"Plasmodium berghei is a unicellular
parasite (protozoan ) and is one of the many species ofmalaria parasites that infect mammals other than humans."P. berghei" is one of the four "
Plasmodium " species that have been described in African murinerodent s.The four malaria parasites of African murine rodents:* "Plasmodium berghei"
* "Plasmodium chabaudi "
* "Plasmodium vinckei "
* "Plasmodium yoelii "These are not of direct practical concern to man or his domestic animals. The interest of these parasites is that they are practical
model organisms in the laboratory for the experimental study of humanmalaria .Description
This species was first described by Vincke and Lips in
1948 in theBelgian Congo . Vincke, I.H. and Lips, M. (1948) Un nouveau plasmodium d'un rongeur sauvage du Congo: "Plasmodium berghei" n.sp. Annales de la Société Belge de Médecine Tropicale 28, 97-104 ]Geographical occurrence
"P. berghei" is found in the forests of
Central Africa , where its natural cyclic hosts are the thicket rat ("Grammomys surdaster ") and themosquito ("Anopheles dureni").Research
Rodent malaria parasites are used in many research institutes for studies aiming at the development of new
drugs or avaccine against malaria.In the laboratory the natural hosts have been replaced by a number of commercially available laboratory mouse strains, and the mosquito "
Anopheles stephensi ", which is comparatively easily reared and maintained under defined laboratory conditionsRodent parasites are recognised as valuable model organisms for the investigation of humanmalaria because they are similar in most essential aspects of morphology, physiology and life cycle and the manipulation of the complete lifecycle of these parasites, including mosquito infections, is simple and safe.Like all malaria parasites of
mammals , including the four humanmalaria parasites, "P. berghei" is transmitted by "Anopheles " mosquitoes and it infects the liver after being injected into the bloodstream by a bite of an infected female mosquito. After a short period (a few days) of development and multiplication, these parasites leave the liver and invadeerythrocytes (red blood cells). The multiplication of the parasite in the blood causes the pathology such asanaemia and damage of essential organs of the host such as lungs, liver, spleen. "P. berghei" infections may also affect the brain and can be the cause of cerebral complications in laboratory mice. These symptoms are to a certain degree comparable to symptoms of cerebral malaria in patients infected with the human malaria parasite "Plasmodium falciparum ".The complete
genome of "P. berghei" has been sequenced and it shows a high similarity, both in structure andgene content, with the genome of the human malaria parasite "Plasmodium falciparum "."P. berghei" can be genetically manipulated in the laboratory using standard
genetic engineering technologies. Consequently this parasite is often used for the analysis of the function of malaria genes using the technology ofgenetic modification .A number of genetically modified "P. berghei" lines have been generated which express fluorescent reporter proteins such as
Green Fluorescent Protein (GFP) orbioluminescent reporters such asLuciferase . These transgenic parasites are important tools to study and visualize the parasites in the living hostThe use of this model malaria parasite has provided biologists and medical researchers with more insight into:
- The interactions of malaria parasites with the
immune system .- The process of infection of the liver by malaria parasites.
- The cause of severe pathology, such as cerebral complications in malaria patients. - The infection of the mosquito and transmission of the parasite by the mosquito.
Moreover, "P. berghei" is used in research programs for development and screening of anti-malarial drugs and for the development of an effective vaccine against malaria.
References
External links
;General information about (the biology of) "P. berghei":
* [http://www.lumc.nl/1040/research/malaria/model02.html www.lumc.nl/1040/research/malaria/model02.html];Images of rodent malaria parasites:
* [http://www.culleton.org/rodent.html www.culleton.org/rodent.html];Information about the genome and genes of "P. berghei":
* [http://www.sanger.ac.uk/Projects/P_berghei/ www.sanger.ac.uk/Projects/P_berghei/]
* [http://www.genedb.org/genedb/pberghei/index.jsp www.genedb.org/genedb/pberghei/index.jsp]
* [http://www.plasmodb.org/plasmo/home.jsp www.plasmodb.org/plasmo/home.jsp]
* [http://www.ncbi.nlm.nih.gov/projects/Malaria/Rodent/index.html www.ncbi.nlm.nih.gov/projects/Malaria/Rodent/index.html]
Wikimedia Foundation. 2010.